Myomo Depreciation vs Stock Based Compensation Analysis
MYO Stock | USD 5.62 0.40 7.66% |
Myomo financial indicator trend analysis is infinitely more than just investigating Myomo Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Myomo Inc is a good investment. Please check the relationship between Myomo Depreciation and its Stock Based Compensation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Depreciation vs Stock Based Compensation
Depreciation vs Stock Based Compensation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Myomo Inc Depreciation account and Stock Based Compensation. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Myomo's Depreciation and Stock Based Compensation is 0.8. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Myomo Inc, assuming nothing else is changed. The correlation between historical values of Myomo's Depreciation and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Myomo Inc are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Depreciation i.e., Myomo's Depreciation and Stock Based Compensation go up and down completely randomly.
Correlation Coefficient | 0.8 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Depreciation
Depreciation indicates how much of Myomo Inc value has been used up. For tax purposes Myomo can deduct the cost of the tangible assets it purchases as business expenses. However, Myomo Inc must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most indicators from Myomo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Myomo Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. At this time, Myomo's Tax Provision is very stable compared to the past year. As of the 29th of November 2024, Enterprise Value is likely to grow to about 148.6 M, while Selling General Administrative is likely to drop about 10.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 10.3M | 10.3M | 13.2M | 13.8M | Total Revenue | 13.9M | 15.6M | 19.2M | 20.2M |
Myomo fundamental ratios Correlations
Click cells to compare fundamentals
Myomo Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Myomo fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.6M | 14.7M | 20.1M | 10.2M | 14.6M | 10.4M | |
Other Current Liab | 1.7M | 2.5M | 2.8M | 2.6M | 3.3M | 3.5M | |
Total Current Liabilities | 3.9M | 2.9M | 4.3M | 3.6M | 5.5M | 3.1M | |
Total Stockholder Equity | 1.8M | 11.6M | 15.4M | 6.4M | 9.0M | 4.9M | |
Net Tangible Assets | 1.8M | 11.6M | 15.4M | 6.4M | 7.3M | 7.7M | |
Property Plant And Equipment Net | 155.0K | 263.8K | 908.2K | 703.0K | 839.3K | 881.3K | |
Net Debt | (1.8M) | (12.1M) | (14.8M) | (4.8M) | (6.3M) | (6.6M) | |
Retained Earnings | (56.1M) | (67.7M) | (78.1M) | (88.8M) | (96.9M) | (92.1M) | |
Accounts Payable | 450.1K | 180.5K | 723.4K | 569.7K | 1.1M | 602.4K | |
Cash | 4.5M | 12.2M | 15.5M | 5.3M | 6.9M | 7.5M | |
Non Current Assets Total | 449.2K | 263.8K | 908.2K | 946.5K | 930.6K | 533.7K | |
Non Currrent Assets Other | 219.2K | (263.8K) | 95.3K | 111.0K | 91.2K | 97.0K | |
Other Assets | 294.2K | 263.8K | 19.8M | 111.0K | 127.7K | 121.3K | |
Cash And Short Term Investments | 4.5M | 12.2M | 15.5M | 5.3M | 8.9M | 7.7M | |
Net Receivables | 424.3K | 924.9K | 2.0M | 1.9M | 2.4M | 2.5M | |
Common Stock Shares Outstanding | 553.8K | 3.3M | 5.8M | 7.1M | 29.5M | 31.0M | |
Liabilities And Stockholders Equity | 6.6M | 14.7M | 20.1M | 10.2M | 14.6M | 10.4M | |
Non Current Liabilities Total | 890.5K | 274.7K | 402.9K | 200.7K | 115.2K | 109.4K | |
Capital Surpluse | 58.0M | 79.3M | 93.5M | 95.1M | 109.4M | 114.8M | |
Inventory | 439.5K | 707.1K | 808.3K | 1.4M | 1.8M | 1.9M | |
Other Current Assets | 820.2K | 1.1M | 1.7M | 573.5K | 598.9K | 681.3K | |
Other Stockholder Equity | 58.0M | 79.3M | 93.5M | 95.1M | 105.8M | 58.8M | |
Total Liab | 4.8M | 3.1M | 4.7M | 3.8M | 5.6M | 4.0M | |
Total Current Assets | 6.1M | 14.4M | 19.2M | 9.2M | 13.7M | 9.9M | |
Short Term Debt | 1.8M | 36.6K | 666.8K | 457.6K | 972.3K | 876.3K | |
Common Stock | 57.0 | 457.0 | 687.0 | 775.0 | 2.7K | 2.9K | |
Property Plant Equipment | 155.0K | 95.0K | 908.2K | 703.0K | 808.5K | 848.9K | |
Deferred Long Term Liab | 44.0K | 144.6K | 219.2K | 1.5K | 1.3K | 1.3K | |
Current Deferred Revenue | 3.0K | 2.5K | 192.8K | 20.7K | 8.5K | 8.1K | |
Common Stock Total Equity | 1.1K | 1.2K | 57.0 | 457.0 | 411.3 | 477.6 | |
Property Plant And Equipment Gross | 155.0K | 263.8K | 1.3M | 703.0K | 1.6M | 1.7M | |
Cash And Equivalents | 4.5M | 12.2M | 15.5M | 5.3M | 6.1M | 9.1M | |
Net Invested Capital | 4.5M | 11.6M | 15.4M | 6.4M | 9.0M | 10.3M |
Pair Trading with Myomo
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.Moving together with Myomo Stock
Moving against Myomo Stock
0.77 | EKSO | Ekso Bionics Holdings | PairCorr |
0.58 | VERO | Venus Concept | PairCorr |
0.58 | DRIO | DarioHealth Corp | PairCorr |
The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.
The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.835 | Quarterly Revenue Growth 0.813 | Return On Assets (0.31) | Return On Equity (0.83) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.